As capital rotates toward select U.S.-based innovation stories heading into early 2026, a group of small-cap names across regulated fintech, wireless infrastructure, immuno-oncology, and medical technology is drawing increased investor attention. High Roller Technologies (NYSE: ROLR), SurgePays (NASDAQ: SURG), ImmunityBio (NASDAQ: IBRX), and ENDRA Life Sciences (NASDAQ: NDRA) each represent distinct sector-driven catalysts that align with current macro themes, regulatory momentum, and platform-scale potential.
Under the proposed deal, CDNA, a CFTC-registered exchange and clearinghouse affiliated with Crypto.com, will provide event-based prediction market contracts to users through HighRoller.com.
LAS VEGAS, NV / ACCESS Newswire / June 9, 2025 / High Roller Technologies, Inc. announced that Ben Clemes, CEO, and Seth Young, SVP Corporate Strategy & Investor Relations, will be presenting at the Investor Summit Virtual taking place on June 10.
High Roller Technologies, Inc. (“High Roller” and the “Company”) (NYSEAmerican:ROLR), operator of High Roller and Fruta, each a premium brand in online gaming and a
High Roller Technologies, Inc. (“High Roller” and the “Company”) (NYSEAmerican:ROLR), operator of High Roller and Fruta, each a premium brand in online gaming and a
High Roller Technologies, Inc. (“High Roller” and the “Company”) (NYSEAmerican:ROLR), operator of High Roller and Fruta, each a premium brand in online gaming and a
